# OnCo record fgfr3-receptor (target). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/targets/fgfr3-receptor/>
  a schema:BioChemEntity ;
  onco:kind "target" ;
  schema:identifier "fgfr3-receptor" ;
  schema:name "FGFR3"@en ;
  schema:description "A growth-factor receptor that is mutated or fused in a sizeable minority of bladder cancers. Erdafitinib blocks it and is the first targeted drug approved for urothelial cancer selected by a genomic test."@en ;
  schema:url <https://onco.cc/targets/fgfr3-receptor/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Fibroblast_growth_factor_receptor_3>, <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:3690>, <https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000068078>, <https://www.uniprot.org/uniprotkb/P22607/entry>, <https://www.ncbi.nlm.nih.gov/gene/2261> ;
  schema:citation <https://www.uniprot.org/uniprotkb/P22607/entry> ;
  schema:alternateName "FGFR3" ;
  onco:targetClass "kinase" ;
  onco:firstDescribed "1990"^^xsd:gYear ;
  onco:related <https://onco.cc/targets/fgfr2/>, <https://onco.cc/biomarkers/fgfr3-alteration/> ;
  onco:cancers <https://onco.cc/cancers/urothelial/> ;
  onco:drugs <https://onco.cc/drugs/erdafitinib/> ;
  onco:trials <https://onco.cc/trials/thor/> .